Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

New preferred providers for Direct Ship Drug Program and IVIG/SCIG home infusion

January 29, 2016

[

Effective March 1, 2016, Independence will have new preferred providers for both our Direct Ship Drug Program and for intravenous and subcutaneous immunoglobulin (IVIG/SCIG) drugs provided in the home. These changes will not affect medical necessity criteria or coverage determinations for our members.

Direct Ship Drug Program

Walgreens and PerformRx, independent companies, have been chosen as preferred providers for our Direct Ship Drug Program. All requests for direct ship drugs will be fulfilled by these providers, with the exception of Synagis®, which will continue to be fulfilled by ACRO Pharmaceutical Services, an independent company.

Providers who currently order drugs through the Direct Ship Drug Program will be contacted in the next few weeks to ensure there are no gaps in drug fulfillment.

For more information on ordering drugs, go to our Direct Ship Drug Program website.

Home infusion IVIG/SCIG

Option Care, an independent company, has been selected as the preferred provider for IVIG/SCIG drugs given in the home. Members who receive IVIG/SCIG from home infusion vendors that are not owned by a hospital or health system in the Independence provider network will be transitioned to Option Care.

Independence recently sent letters to affected members notifying them of this change and detailing the transition plan of service. Option Care will also provide outreach to these members to answer questions and schedule appointments with an Option Care home infusion nurse. In addition, Option Care will contact affected providers to answer questions and obtain new prescriptions for our members prior to the March 1, 2016, transition date.

Providers should talk to their Independence members who currently receive IVIG/SCIG drugs to see if they have any questions or concerns.

Note: Members who currently receive IVIG/SCIG drugs through home infusion vendors that are owned by a hospital or health system in the Independence provider network will not be affected by this change.

]

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.